查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1378874

骨質疏鬆症藥物市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Osteoporosis Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球骨質疏鬆藥物市場規模達到158億美元。展望未來， IMARC Group預計到2028年市場規模將達到210億美元，2022-2028年複合年成長率（CAGR）為4.9%。

骨質疏鬆症是一種會導致骨組織和強度退化的疾病。透過執行不同的掃描來診斷，例如 X 光、電腦斷層掃描 (CT) 和磁振造影 (MRI)。目前有多種不同劑型的藥物可供選擇，從一般藥片到靜脈注射（IV）輸液，用於緩解骨質疏鬆症的症狀。這些藥物有助於恢復吸收和形成的平衡，修復骨骼的微觀缺陷，降低骨折風險並提高患者的整體肌肉力量。

由於久坐的生活方式、過量飲酒和菸草使用量的增加，骨質疏鬆症的盛行率不斷上升，這是推動市場成長的關鍵因素。患有乳糜瀉、腎臟或肝臟疾病、癌症、紅斑性狼瘡、多發性骨髓瘤和類風濕性關節炎的人數不斷增加，進一步加速了市場的成長。此外，骨質流失隨著年齡的成長而增加，這增加了老年人骨質疏鬆症的風險。因此，不斷成長的老年人口正在對全球骨質疏鬆症藥物的需求產生積極影響。此外，一些管理機構正在開發新的療法，這有助於市場的成長。例如，美國食品藥物管理局 (FDA) 已批准針對骨折風險高或對其他骨質疏鬆症治療不耐受的停經後婦女使用新型骨質疏鬆症藥物。除此之外，預計處於後期臨床試驗的多種藥物將推動未來幾年的市場成長。

本報告回答的關鍵問題

  • 全球骨質疏鬆藥物市場有多大？
  • 2023-2028年全球骨質疏鬆藥物市場的預期成長率為何？
  • 推動全球骨質疏鬆藥物市場的關鍵因素是什麼？
  • COVID-19 對全球骨質疏鬆症藥物市場有何影響？
  • 根據產品類型，全球骨質疏鬆症藥物市場的細分如何？
  • 根據給藥途徑，全球骨質疏鬆症藥物市場的細分如何？
  • 全球骨質疏鬆藥物市場的重點區域有哪些？
  • 全球骨質疏鬆症藥物市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球骨質疏鬆藥物市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：依產品類型分類的市場區隔

  • 雙磷酸鹽
    • 市場走向
    • 市場預測
  • 降鈣素
    • 市場走向
    • 市場預測
  • Rank 配體抑制劑
    • 市場走向
    • 市場預測
  • 副甲狀腺素治療 (PTH)
    • 市場走向
    • 市場預測
  • 選擇性雌激素受體調節劑 (SERM)
    • 市場走向
    • 市場預測
  • 硬化素抑制劑
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：按管理途徑分類的市場

  • 口服
    • 市場走向
    • 市場預測
  • 可注射
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Amgen Inc.
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline Plc
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Radius Health Inc.
    • Teva Pharmaceutical Industries Ltd.
    • UCB SA
Product Code: SR112023A3104

Abstract

The global osteoporosis drugs market size reached US$ 15.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 21.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2022-2028.

Osteoporosis is a disease that causes deterioration of bone tissues and strength. It is diagnosed by performing different scans, such as X-ray, computed tomography (CT) and magnetic resonance imaging (MRI). Various drugs are currently available in different formulations, ranging from regular tablets to intravenous (IV) infusions, for alleviating the symptoms of osteoporosis. These drugs help restore the balance of resorption and formation, repair microscopic defects in bones, reduce the risk of fractures and improve the overall muscle strength of the patients.

The growing prevalence of osteoporosis on account of sedentary lifestyles, excessive consumption of alcohol, and rising utilization of tobacco represent the key factors bolstering the growth of the market. The increasing number of individuals who have celiac disease, kidney or liver disease, cancer, lupus, multiple myeloma and rheumatoid arthritis is further accelerating the market growth. Moreover, bone mass loss increases with age, which raises the risk of developing osteoporosis among older people. Consequently, the rising geriatric population is positively influencing the demand for osteoporosis drugs worldwide. Furthermore, several governing authorities are developing novel therapeutics, which is contributing to the market growth. For instance, the US Food and Drug Administration (FDA) has approved novel osteoporosis drugs for postmenopausal women who are at a high risk of fractures or are intolerant to other osteoporosis therapies. Besides this, a wide range of drugs in late-stage clinical trials is anticipated to propel the market growth in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global osteoporosis drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and route of administration.

Breakup by Product Type:

Bisphosphonates

Calcitonin

Rank Ligand Inhibitor

Parathyroid Hormone Therapy (PTH)

Selective Estrogen Receptor Modulators (SERMs)

Sclerostin Inhibitor

Others

Breakup by Route of Administration:

Oral

Injectable

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Radius Health Inc., Teva Pharmaceutical Industries Ltd. and UCB S.A.

Key Questions Answered in This Report

  • 1. How big is the global osteoporosis drugs market?
  • 2. What is the expected growth rate of the global osteoporosis drugs market during 2023-2028?
  • 3. What are the key factors driving the global osteoporosis drugs market?
  • 4. What has been the impact of COVID-19 on the global osteoporosis drugs market?
  • 5. What is the breakup of the global osteoporosis drugs market based on the product type?
  • 6. What is the breakup of the global osteoporosis drugs market based on the route of administration?
  • 7. What are the key regions in the global osteoporosis drugs market?
  • 8. Who are the key players/companies in the global osteoporosis drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Osteoporosis Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Bisphosphonates
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Calcitonin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Rank Ligand Inhibitor
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Parathyroid Hormone Therapy (PTH)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Selective Estrogen Receptor Modulators (SERMs)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Sclerostin Inhibitor
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Injectable
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Amgen Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Eli Lilly and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 F. Hoffmann-La Roche AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 GlaxoSmithKline Plc
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Merck & Co. Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Novartis AG
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Pfizer Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Radius Health Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Teva Pharmaceutical Industries Ltd.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 UCB S.A.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Osteoporosis Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Osteoporosis Drugs Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Osteoporosis Drugs Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Osteoporosis Drugs Market: Breakup by Route of Administration (in %), 2022
  • Figure 5: Global: Osteoporosis Drugs Market: Breakup by Region (in %), 2022
  • Figure 6: Global: Osteoporosis Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 7: Global: Osteoporosis Drugs (Bisphosphonates) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Osteoporosis Drugs (Bisphosphonates) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Osteoporosis Drugs (Calcitonin) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Osteoporosis Drugs (Calcitonin) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Osteoporosis Drugs (Rank Ligand Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Osteoporosis Drugs (Rank Ligand Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Osteoporosis Drugs (Parathyroid Hormone Therapy- PTH) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Osteoporosis Drugs (Parathyroid Hormone Therapy- PTH) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Osteoporosis Drugs (Selective Estrogen Receptor Modulators- SERMs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Osteoporosis Drugs (Selective Estrogen Receptor Modulators- SERMs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Osteoporosis Drugs (Sclerostin Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Osteoporosis Drugs (Sclerostin Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Osteoporosis Drugs (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Osteoporosis Drugs (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Osteoporosis Drugs (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Osteoporosis Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Osteoporosis Drugs (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Osteoporosis Drugs (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Osteoporosis Drugs (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Osteoporosis Drugs (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: North America: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: North America: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: United States: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: United States: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Canada: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Canada: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Asia-Pacific: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Asia-Pacific: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: China: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: China: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Japan: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Japan: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: India: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: India: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: South Korea: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: South Korea: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Australia: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Australia: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Indonesia: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Indonesia: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Others: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Europe: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Europe: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Germany: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Germany: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: France: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: France: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: United Kingdom: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: United Kingdom: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Italy: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Italy: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Spain: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Spain: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Russia: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Russia: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Latin America: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Latin America: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Brazil: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Brazil: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Mexico: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Mexico: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Middle East and Africa: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Middle East and Africa: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Middle East and Africa: Osteoporosis Drugs Market: Breakup by Country (in %), 2022
  • Figure 76: Global: Osteoporosis Drugs Industry: SWOT Analysis
  • Figure 77: Global: Osteoporosis Drugs Industry: Value Chain Analysis
  • Figure 78: Global: Osteoporosis Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Osteoporosis Drugs Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Osteoporosis Drugs Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Osteoporosis Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Osteoporosis Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Osteoporosis Drugs Market: Competitive Structure
  • Table 6: Global: Osteoporosis Drugs Market: Key Players